BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 26341012)

  • 1. The role of thioredoxin reductase and glutathione reductase in plumbagin-induced, reactive oxygen species-mediated apoptosis in cancer cell lines.
    Hwang GH; Ryu JM; Jeon YJ; Choi J; Han HJ; Lee YM; Lee S; Bae JS; Jung JW; Chang W; Kim LK; Jee JG; Lee MY
    Eur J Pharmacol; 2015 Oct; 765():384-93. PubMed ID: 26341012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plumbagin induces cell cycle arrest and apoptosis through reactive oxygen species/c-Jun N-terminal kinase pathways in human melanoma A375.S2 cells.
    Wang CC; Chiang YM; Sung SC; Hsu YL; Chang JK; Kuo PL
    Cancer Lett; 2008 Jan; 259(1):82-98. PubMed ID: 18023967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plumbagin induces reactive oxygen species, which mediate apoptosis in human cervical cancer cells.
    Srinivas P; Gopinath G; Banerji A; Dinakar A; Srinivas G
    Mol Carcinog; 2004 Aug; 40(4):201-11. PubMed ID: 15264212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting thioredoxin reductase by plumbagin contributes to inducing apoptosis of HL-60 cells.
    Zhang J; Peng S; Li X; Liu R; Han X; Fang J
    Arch Biochem Biophys; 2017 Apr; 619():16-26. PubMed ID: 28249720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plumbagin engenders apoptosis in lung cancer cells via caspase-9 activation and targeting mitochondrial-mediated ROS induction.
    Tripathi SK; Rengasamy KRR; Biswal BK
    Arch Pharm Res; 2020 Feb; 43(2):242-256. PubMed ID: 32034669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone) induces apoptosis and cell cycle arrest in A549 cells through p53 accumulation via c-Jun NH2-terminal kinase-mediated phosphorylation at serine 15 in vitro and in vivo.
    Hsu YL; Cho CY; Kuo PL; Huang YT; Lin CC
    J Pharmacol Exp Ther; 2006 Aug; 318(2):484-94. PubMed ID: 16632641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of both thioredoxin reductase and glutathione reductase may contribute to the anticancer mechanism of TH-302.
    Li S; Zhang J; Li J; Chen D; Matteucci M; Curd J; Duan JX
    Biol Trace Elem Res; 2010 Sep; 136(3):294-301. PubMed ID: 19838642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The variable chemotherapeutic response of Malabaricone-A in leukemic and solid tumor cell lines depends on the degree of redox imbalance.
    Manna A; De Sarkar S; De S; Bauri AK; Chattopadhyay S; Chatterjee M
    Phytomedicine; 2015 Jul; 22(7-8):713-23. PubMed ID: 26141757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plumbagin from a tropical pitcher plant (Nepenthes alata Blanco) induces apoptotic cell death via a p53-dependent pathway in MCF-7 human breast cancer cells.
    De U; Son JY; Jeon Y; Ha SY; Park YJ; Yoon S; Ha KT; Choi WS; Lee BM; Kim IS; Kwak JH; Kim HS
    Food Chem Toxicol; 2019 Jan; 123():492-500. PubMed ID: 30458268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plumbagin induces apoptosis via the p53 pathway and generation of reactive oxygen species in human osteosarcoma cells.
    Tian L; Yin D; Ren Y; Gong C; Chen A; Guo FJ
    Mol Med Rep; 2012 Jan; 5(1):126-32. PubMed ID: 21993662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of thioredoxin reductase by mansonone F analogues: Implications for anticancer activity.
    Liu Z; Huang SL; Li MM; Huang ZS; Lee KS; Gu LQ
    Chem Biol Interact; 2009 Jan; 177(1):48-57. PubMed ID: 18822278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EM23, a natural sesquiterpene lactone, targets thioredoxin reductase to activate JNK and cell death pathways in human cervical cancer cells.
    Shao FY; Wang S; Li HY; Chen WB; Wang GC; Ma DL; Wong NS; Xiao H; Liu QY; Zhou GX; Li YL; Li MM; Wang YF; Liu Z
    Oncotarget; 2016 Feb; 7(6):6790-808. PubMed ID: 26758418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of apoptosis by plumbagin through reactive oxygen species-mediated inhibition of topoisomerase II.
    Kawiak A; Piosik J; Stasilojc G; Gwizdek-Wisniewska A; Marczak L; Stobiecki M; Bigda J; Lojkowska E
    Toxicol Appl Pharmacol; 2007 Sep; 223(3):267-76. PubMed ID: 17618663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Auranofin, an inhibitor of thioredoxin reductase, induces apoptosis in hepatocellular carcinoma Hep3B cells by generation of reactive oxygen species.
    Hwang-Bo H; Jeong JW; Han MH; Park C; Hong SH; Kim GY; Moon SK; Cheong J; Kim WJ; Yoo YH; Choi YH
    Gen Physiol Biophys; 2017 Apr; 36(2):117-128. PubMed ID: 28218611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The combination of plumbagin with androgen withdrawal causes profound regression of prostate tumors in vivo.
    Abedinpour P; Baron VT; Chrastina A; Welsh J; Borgström P
    Prostate; 2013 Apr; 73(5):489-99. PubMed ID: 22996809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indolin-2-one compounds targeting thioredoxin reductase as potential anticancer drug leads.
    Kaminska KK; Bertrand HC; Tajima H; Stafford WC; Cheng Q; Chen W; Wells G; Arner ES; Chew EH
    Oncotarget; 2016 Jun; 7(26):40233-40251. PubMed ID: 27244886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Butaselen prevents hepatocarcinogenesis and progression through inhibiting thioredoxin reductase activity.
    Zheng X; Ma W; Sun R; Yin H; Lin F; Liu Y; Xu W; Zeng H
    Redox Biol; 2018 Apr; 14():237-249. PubMed ID: 28965082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer cell death induced by phosphine gold(I) compounds targeting thioredoxin reductase.
    Gandin V; Fernandes AP; Rigobello MP; Dani B; Sorrentino F; Tisato F; Björnstedt M; Bindoli A; Sturaro A; Rella R; Marzano C
    Biochem Pharmacol; 2010 Jan; 79(2):90-101. PubMed ID: 19665452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of AMP-activated protein kinase (AMPK) mediates plumbagin-induced apoptosis and growth inhibition in cultured human colon cancer cells.
    Chen MB; Zhang Y; Wei MX; Shen W; Wu XY; Yao C; Lu PH
    Cell Signal; 2013 Oct; 25(10):1993-2002. PubMed ID: 23712032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-talk between two antioxidants, thioredoxin reductase and heme oxygenase-1, and therapeutic implications for multiple myeloma.
    Raninga PV; Di Trapani G; Vuckovic S; Tonissen KF
    Redox Biol; 2016 Aug; 8():175-85. PubMed ID: 26795735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.